Q2 2013

Filed Aug 6, 2013 · 10-Q · 37 days after period end · 0000877860-13-000076

Q2 2013 · 10-Q

Revenue

$27.09M

+29.5% vs Q2 2012

Net Income

$19.92M

+17.7% vs Q2 2012

EPS Diluted

$0.71

+16.4% vs Q2 2012

Operating Income$19,254,000+22.8%

Operating Cash Flow

Same quarter

Metric	Q2 2013	Q2 2012	Q2 2011	Q2 2010
Revenue	$27.09M	$20.92M	$21.37M	$19.01M
Net Income	$19.92M	$16.93M	$25.12M	$19.19M
EPS Diluted	$0.71	$0.61	$0.90	$0.69

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR